Additional file 2: Table S1. of Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial

Summary of MRI endpoints over 2 years by original randomisation group [6]. (DOC 53kb)

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.6084/m9.figshare.c.3688261_d2.v1
PID https://www.doi.org/10.6084/m9.figshare.c.3688261_d2
URL http://dx.doi.org/10.6084/m9.figshare.c.3688261_d2.v1
URL http://dx.doi.org/10.6084/m9.figshare.c.3688261_d2
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Arnold, Douglas
Author Calabresi, Peter
Author Kieseier, Bernd
Author Shifang Liu
Author Xiaojun You
Author Fiore, Damian
Author Hung, Serena
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From Datacite; figshare
Hosted By figshare
Publication Date 2017-02-10
Publisher Figshare
Additional Info
Field Value
Language UNKNOWN
Resource Type Other literature type
keyword FOS: Biological sciences
keyword FOS: Computer and information sciences
keyword FOS: Mathematics
keyword FOS: Clinical medicine
system:type publication
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/publication?articleId=dedup_wf_001::d16f7ea5b48b0bfcb221014b53be98df
Author jsonws_user
Last Updated 27 December 2020, 00:17 (CET)
Created 27 December 2020, 00:17 (CET)